Akti-1/2
Chemical Name: 1,3-Dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]-4-piperidinyl]-2H-benzimidazol-2-one
Purity: ≥98%
Biological Activity
Akti-1/2 is a potent and selective dual Akt1 and 2 inhibitor (IC50 values are 50 and 210 nM, respectively). Selective for Akt1 and 2 over a panel of other tyrosine and serine/threonine kinases. Sensitizes LnCaP cells to TRAIL (TNF-related apoptosis-inducing ligand) induced apoptosis. Also enhances CAR and TCR retroviral transduction of human T cells. Active in vivo.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
The selectivity of protein kinase inhibitors: a further update.
Bain et al.
Biochem.J., 2007;408:297 -
Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members.
DeFeo-Jones D et al.
Mol.Cancer Ther., 2005;4:271 -
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.
Barnett et al.
Biochem. J., 2005;385:399 -
Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors.
Lindsley et al.
Bioorg.Med.Chem.Lett., 2005;15:761 -
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.
Klebanoff et al.
JCI Insight, 2017;2:e95103
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for Akti-1/2
The citations listed below are publications that use Tocris products. Selected citations for Akti-1/2 include:
11 Citations: Showing 1 - 10
-
TSC22D4 interacts with Akt1 to regulate glucose metabolism.
Authors: Adriano Et al.
Sci Adv 2022;8:eabo5555
-
Pannexin-1 Activation by Phosphorylation Is Crucial for Platelet Aggregation and Thrombus Formation.
Authors: Margitta Et al.
Int J Mol Sci 2022;23
-
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism.
Authors: Claudio Et al.
Mol Oncol 2022;16:188-205
-
Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion.
Authors: Aurélie Et al.
Cancers (Basel) 2022;14
-
Regulation of Stress-Activated Kinases in Response to Tacaribe Virus Infection and Its Implications for Viral Replication.
Authors: Lucie Et al.
Viruses 2022;14
-
EGFR Activates a TAZ-Driven Oncogenic Program in Glioblastoma.
Authors: Charles G Et al.
Cancer Res 2021;81:3580-3592
-
Gαq activation modulates autophagy by promoting mTORC1 signaling.
Authors: Anna M Et al.
Nat Commun 2021;12:4540
-
Characterization of a novel compound that promotes myogenesis via Akt and transcriptional co-activator with PDZ-binding motif (TAZ) in mouse C2C12 cells.
Authors: Kodaka Et al.
PLoS One 2020;15:e0231265
-
Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease.
Authors: Viviana I Et al.
J Neurochem 2019;149:54-72
-
Tyro3 is a podocyte protective factor in glomerular disease.
Authors: Zhong Et al.
JCI Insight 2018;3
-
Autocrine-paracrine prostaglandin E2 signaling restricts TLR4 internalization and TRIF signaling.
Authors: Perkins Et al.
Nat.Immunol. 2018;19:1309
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Akti-1/2
There are currently no reviews for this product. Be the first to review Akti-1/2 and earn rewards!
Have you used Akti-1/2?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
